Home/Filings/4/0001225208-25-005273
4//SEC Filing

TOOKER ADIN M 4

Accession 0001225208-25-005273

CIK 0000874766other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 4:04 PM ET

Size

35.1 KB

Accession

0001225208-25-005273

Insider Transaction Report

Form 4
Period: 2025-05-15
TOOKER ADIN M
President
Transactions
  • Sale

    Common Stock

    2025-05-15$128.00/sh3,583$458,60740,029.067 total
  • Sale

    Common Stock

    2025-05-15$128.01/sh4,303$550,82231,721.067 total
  • Exercise/Conversion

    Common Stock

    2025-05-15$53.81/sh+8,308$447,05340,029.067 total
  • Sale

    Common Stock

    2025-05-15$129.28/sh3,281$424,15647,175.067 total
  • Sale

    Common Stock

    2025-05-15$129.26/sh4,005$517,69536,024.067 total
  • Exercise/Conversion

    Stock Option

    2025-05-156,7316,731 total
    Exercise: $48.89Exp: 2027-02-28Common Stock (6,731 underlying)
  • Exercise/Conversion

    Stock Option

    2025-05-156,8640 total
    Exercise: $43.59Exp: 2026-03-01Common Stock (6,864 underlying)
  • Sale

    Common Stock

    2025-05-15$129.28/sh3,168$409,57350,456.067 total
  • Sale

    Common Stock

    2025-05-15$128.02/sh3,563$456,12643,612.067 total
  • Exercise/Conversion

    Stock Option

    2025-05-158,30816,614 total
    Exercise: $53.81Exp: 2028-02-27Common Stock (8,308 underlying)
  • Exercise/Conversion

    Common Stock

    2025-05-15$43.59/sh+6,864$299,20246,893.067 total
  • Exercise/Conversion

    Common Stock

    2025-05-15$48.89/sh+6,731$329,07953,624.067 total
Holdings
  • Stock Option

    Exercise: $55.27Exp: 2030-02-25Common Stock (24,094 underlying)
    24,094
  • Stock Option

    Exercise: $78.28Exp: 2033-02-28Common Stock (24,301 underlying)
    24,301
  • Stock Option

    Exercise: $116.41Exp: 2035-02-25Common Stock (25,488 underlying)
    25,488
  • Stock Option

    Exercise: $51.87Exp: 2031-02-23Common Stock (25,202 underlying)
    25,202
  • Stock Option

    Exercise: $49.01Exp: 2029-02-26Common Stock (26,687 underlying)
    26,687
  • Stock Option

    Exercise: $69.41Exp: 2032-02-23Common Stock (24,155 underlying)
    24,155
  • Stock Option

    Exercise: $95.74Exp: 2034-02-27Common Stock (16,492 underlying)
    16,492
Footnotes (17)
  • [F1]The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Tooker on August 14, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
  • [F10]The options became fully exercisable on March 1, 2019, the third anniversary of the grant date.
  • [F11]The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
  • [F12]The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
  • [F13]The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
  • [F14]The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
  • [F15]One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
  • [F16]One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
  • [F17]One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
  • [F2]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $128.69 - $129.63 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $128.65 - $129.60 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F4]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $127.64 - $128.61 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F5]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $127.64 - $128.52 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F6]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $128.68 - $129.64 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F7]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $127.67 - $128.65 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F8]The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
  • [F9]The options became fully exercisable on February 28, 2020, the third anniversary of the grant date.

Documents

1 file

Issuer

HARTFORD INSURANCE GROUP, INC.

CIK 0000874766

Entity typeother

Related Parties

1
  • filerCIK 0001953211

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:04 PM ET
Size
35.1 KB